Tomoaki Shintani
- Periodontics top 5%
- Oral microbiology and periodontitis research 10
- Biotechnology top 10%
-
- Cancer, Hypoxia, and Metabolism 5
-
- Cancer Cells and Metastasis 4
-
- Fibroblast Growth Factor Research 9
- Angiogenesis and VEGF in Cancer 4
-
- Lung Cancer Treatments and Mutations 4
-
- Hippo pathway signaling and YAP/TAZ 4
-
- Atrial Fibrillation Management and Outcomes 3
- Co-authors
- Tetsuji OkamotoShigeaki TorataniSatoshi ItasakaYasutaka HayashidoRoy S. HerbstMichael S. O’ReillyMakoto OjikaKeiko Shibuya
- Journals
- In Vitro Cellular & Developmental Biology - Animal (6 papers)PLoS ONE (5 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
- Partner nations
- JapanUnited StatesMalaysia
In The Last Decade
Tomoaki Shintani
57 papers receiving 617 citations
Peers
Comparison fields: 5 of 88
- Periodontics 78
- Biotechnology 78
- Cancer Research 122
- Oncology 154
- Orthodontics 19
Countries citing papers authored by Tomoaki Shintani
This map shows the geographic impact of Tomoaki Shintani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoaki Shintani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoaki Shintani more than expected).
Fields of papers citing papers by Tomoaki Shintani
This network shows the impact of papers produced by Tomoaki Shintani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoaki Shintani. The network helps show where Tomoaki Shintani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomoaki Shintani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 0 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 4 | |
| 14 | 2020 | 4 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 14 | |
| 17 | 2017 | 13 | |
| 18 | 2014 | 20 | |
| 19 | 2013 | 26 | |
| 20 | Targeted therapy against VEGF and EGF receptor signaling with ZD6474 blocks angiogenesis and inhibits the growth and dissemination of orthotopic human lung cancer in mice. | 2003 | 1 |
About Tomoaki Shintani
Tomoaki Shintani is a scholar working on Periodontics, Complementary and Manual Therapy and Oncology, having authored 66 papers that have together received 634 indexed citations. Recurring topics across this work include Oral microbiology and periodontitis research (10 papers), Fibroblast Growth Factor Research (9 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer Cells and Metastasis (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). The work is most often cited by research in Periodontics (78 citations), Biotechnology (78 citations) and Cancer Research (122 citations). Tomoaki Shintani has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Tetsuji Okamoto, Shigeaki Toratani, Satoshi Itasaka, Yasutaka Hayashido, Roy S. Herbst, Michael S. O’Reilly, Makoto Ojika, Keiko Shibuya, Emiko Usui and Hidemi Kurihara. Their work appears in journals such as In Vitro Cellular & Developmental Biology - Animal, PLoS ONE, International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.